This call is one of four themes in a Cross-council initiative part funded by BBSRC and led by MRC. The focus of the call is to drive forward innovative high quality multidisciplinary collaborative research to address the broad challenges presented in theme 1 in order to: understand the resistant bacterium at molecular, cell and population levels; understand the context of host/pathogen interactions in humans and animals; identify and validate novel targets for new antibacterials; understand transmission of resistance in humans and animals.
This call is one of four themes in a Cross-council initiative part funded by BBSRC and led by MRC. This theme encompasses the development, scale up and manufacture of new antibiotic therapies and the diagnostics required to better target new and existing therapies and to monitor spread.
Together with the Engineering and Physical Sciences Research Council (EPSRC) and the Technology Strategy Board (TSB) we are committed to supporting the development and commercialisation of innovative Industrial Biotechnology (IB) processes (see strategic plan in related links) arising from the UK's excellent research base.
To continue to encourage UK-US collaborations, BBSRC and NIA have established a co-funding scheme whereby BBSRC will support the UK component of joint UK-US projects submitted to the NIA grant funding system. Currently, up to £2M is available for this scheme.
University of Glasgow
College of Medical, Veterinary & Life Sciences
Wolfson Medical School Building, University Avenue, Glasgow, G12 8QQ, Scotland
General enquiries: +44 (0) 141 330 5921
Head of College enquiries: email@example.com
Head of College phone: +44 (0)141 330 2738